BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10889385)

  • 1. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial.
    Syed AM; Puthawala AA; Damore SJ; Cherlow JM; Austin PA; Sposto R; Ramsinghani NS
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1311-21. PubMed ID: 10889385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
    Hwang JM; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.
    Lee N; Hoffman R; Phillips TL; Xia P; Quivey JM; Weinberg V; Hsu IC
    Brachytherapy; 2002; 1(2):74-82. PubMed ID: 15062174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
    Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
    Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
    Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-treatment of nasopharyngeal carcinoma in 53 patients.
    Pryzant RM; Wendt CD; Delclos L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1992; 22(5):941-7. PubMed ID: 1555986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Chen YQ; Deng XG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
    Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
    Ozyar E; Yildz F; Akyol FH; Atahan IL
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy.
    Koutcher L; Lee N; Zelefsky M; Chan K; Cohen G; Pfister D; Kraus D; Wolden S
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):130-7. PubMed ID: 19467802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
    Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
    Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
    Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
    Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation of locally recurrent nasopharyngeal carcinoma.
    Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
    Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost.
    Wang CC
    Am J Clin Oncol; 1991 Feb; 14(1):5-8. PubMed ID: 1987739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.